CAPRICOR THERAPEUTICS INC (CAPR) Stock Income Statement
NASDAQ:CAPR - Nasdaq - US14070B3096 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.27M | 25.18M | 2.55M | 240.00K | 310.00K | |||
| Operating Expenses | 41.79M | 30.59M | 24.78M | 16.09M | 10.60M | |||
| Research and Development | 26.15M | 17.15M | 13.93M | 8.47M | 5.06M | |||
| Selling, General, and Administrative Expenses | 14.22M | 12.81M | 10.43M | 7.61M | 5.54M | |||
| Operating Income | -19.52M | -5.41M | -22.23M | -15.84M | -10.29M | |||
| Interest Income/Expense | 2.20M | 1.73M | 520.00K | 60.00K | 30.00K | |||
| Other Income/Expense | 7.50K | 67.70K | 190.00K | 550.00K | N/A | |||
| Non Recurring Items | -23.05M | -18.67M | -7.47M | -4.78M | -3.40M | |||
| Income Before Taxes | -40.47M | -22.29M | -29.02M | -20.02M | -13.66M | |||
| Net Income | -40.47M | -22.29M | -29.02M | -20.02M | -13.66M | |||
| EBITDA | -18.09M | -4.34M | -21.70M | -15.59M | -10.15M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.15 | -0.83 | -1.18 | -0.87 | -0.88 | |||
| Non GAAP EPS | -1.20 | -0.87 | N/A | -0.87 | -0.94 | |||
| Statistics | ||||||||
| Profit Margin | -181.71% | -88.52% | -1138.04% | -8341.67% | -4406.45% | |||
| Operating Profit Margin | -87.63% | -21.49% | -871.76% | -6600.00% | -3319.35% | |||
All data in USD